In prenatal dental care, the “Second Trimester Safe Zone” (14–20 weeks) is often treated as dogma. We are trained to defer definitive care in the third trimester due to concerns regarding supine hypotensive syndrome and patient comfort. However, a 2025 study by Pathak et al. challenges this constraint, offering compelling evidence that third-trimester intervention is not only safe
but clinically effective in improving birth weight.
Here is the breakdown of the findings and the critical nuances for your clinical practice.
The Protocol: Definitive vs. Superficial Management
The study recruited 56 pregnant women with chronic periodontitis in their third trimester. Unlike designs that compare “treatment” vs. “no treatment,” this study controlled for the placebo effect of visiting the dentist:
- Case Group (Definitive Therapy): Received subgingival scaling and root planing (SRP). Notably, this protocol included adjunctive systemic amoxicillin and 0.2% Chlorhexidine mouthwash.
- Control Group (Partial Therapy): Received only supragingival scaling and a placebo.
The Results: A 290g Difference
While periodontal parameters (BOP, PPD, CAL) improved significantly in the test group ($P=0.000$), the obstetric outcomes offer the most striking data.
- Case Group Mean Birth Weight: 2.92 kg
- Control Group Mean Birth Weight: 2.63 kg
The intervention group’s infants weighed, on average, 290g more ($P=0.011$). In obstetrics, this is a massive margin, effectively moving an infant away from the Low Birth Weight (LBW) threshold (<2.5 kg). Importantly, no adverse events were recorded, confirming safety despite the late stage of pregnancy.
Three Clinical Nuances to Consider
1. The “Subgingival” Differentiator
The control group received supragingival scaling but still had significantly lower birth weights.
This reinforces that subgingival biofilm and the ulcerated pocket epithelium are the true sources of systemic dissemination. Simply removing visible calculus (supragingival) is insufficient to cut the link between oral infection and placental inflammation. The inflammatory mediators (IL-1, IL-6, PGE2) must be managed via deep instrumentation.
2. The “11th Hour” Growth Spurt
The data suggests that fetal growth restriction caused by periodontitis is not necessarily “permanent” or set early in gestation. By removing the inflammatory “brake” in the third trimester, the fetus appears to undergo a period of catch-up growth. This validates treating a patient at 32 weeks rather than assuming “the damage is already done.”
3. The Antibiotic Confounder
We must acknowledge the protocol: SRP + Amoxicillin. We cannot definitively state whether the success was solely due to mechanical debridement or if the systemic antibiotic played a dual role (perhaps by managing undiagnosed subclinical infections elsewhere). While routine antibiotic use for periodontitis is not standard guideline-based care in all regions, this specific “maximalist” approach (Mechanical + Chemical + Systemic) proved highly effective in this high-risk cohort.
The Bottom Line
Active management of chronic periodontitis should not be deferred based solely on trimester. The biological benefit—a nearly 300g increase in birth weight—outweighs the logistical challenges of treating a third-trimester patient.
Clinical Recommendation: When a patient presents with periodontitis late in pregnancy, prioritize SRP with proper positioning (semi-reclined, right hip elevated) rather than deferring to postpartum. The window to help the baby is still open.
Reference:
Pathak AK, Belani S, Dixit D, Agrawal M. Effects of periodontal treatment during pregnancy, on prevention of preterm low birth weight: A case control study. Natl J Maxillofac Surg. 2025 Sep-Dec;16(3):498-503. doi: 10.4103/njms.njms_146_24. Epub 2025 Dec 25. PMID: 41585988; PMCID: PMC12829667.
